Trochanteric bursitis, or greater trochanteric pain syndrome (GTPS), is one of the most common causes of hip pain. 1 This condition has traditionally been thought to result from inflammation of one or more bursae about the hip joint, however further evaluation using surgical, MRI and ultrasound imaging suggests there is little or no inflammatory bursal component. 2, 3, 4 Gluteal tendinopathy may be a more correctly descriptive term which involves pathology of the hip abductors similar to the intrinsic changes seen with rotator cuff pathology in the shoulder. 5 A diagnostic label of GTPS takes in to account the lack of evidence of inflammation. The condition appears to some as a muscular dysfunction and there is some association with acetabular anteversion. 6 There are two major bursae of the hip, trochanteric and ischial, which can both be associated with stiffness and pain around the hip joint. The trochanteric bursa is located between the iliotibial band and the greater trochanter of the femur. Trochanteric bursitis frequently causes tenderness of the outer hip, making it difficult for patients to lie on the involved side, frequently making sleep difficult. It also causes a dull, burning pain on the outer hip that is often made worse with excessive walking or stair climbing. The ischial bursa is located in the lower buttock area. It can cause dull pain in this area that is most noticeable climbing up hill. The pain sometimes occurs after prolonged sitting on hard surfaces, hence the names "weaver's bottom" and "tailor's bottom."
Subjective Findings and History
 Etiology: may or may not have history of trauma such as a direct blow or a fall, friction trauma from muscle hypertonicity and overuse (e.g. running on sloped surface, with tight gluteals), genu varum, extreme underpronation, arthritic condition.  Commonly seen in 40-60 year old patients.  Well-localized lateral hip pain; may cause radiating pain in the lateral thigh and knee, rarely into the gluteal or low back.  Patient unable to sleep on the involved side.  Often aggravated by climbing stairs.  Degree of discomfort often proportional to degree of activity.
Objective Findings
 Postural evaluation, walk with limp, leg length inequality.  Orthopedic/neurologic examination: Patrick FABERE, log roll and local tenderness show fair interexaminer concordance. Ober test is less so.  Palpation: Edema and tenderness over the greater trochanter. Tight gluteal muscles.  Palpation at the lower portion of the trochanter with the hip and knee flexed may elicit a "jump" sign (localized tenderness).  Range of motion: decreased internal hip rotation. Joint play: examine SI and hip joint motion.  Can progress to calcific infiltration seen at x-ray.
Assessment
 The clinical impression should indicate the specific anatomical structures involved and clinically correlate them with the mechanism of injury, history, subjective complaints, and objective findings.  Differentiate this condition from iliopectineal and iliopsoas bursitis, which may present with anterior hip pain, and ischial bursitis, which may present with sciatica and pain referred from lumbar spine or SI joint. Also differentiate degenerative joint disease (DJD) of the hip by physical exam or x-ray.  Regional anesthetic block may be helpful in differentiating the pain of trochanteric bursitis from that of referred pain from the lumbosacral spin or other conditions.
Plan
Passive Care:  Manual therapy: manual and instrument assisted soft tissue massage, PNF (Proprioceptive neuromuscular facilitation)/stretching of gluteal and hip abductor muscles.  Joint manipulation of hip and pelvis. Manipulation of any other lower extremity joint dysfunction (Caution: side posture adjusting on involved hip may aggravate condition).  Physical Therapy Modalities: control inflammation and pain.  Kinesiotape. 7  Supplementation to control inflammation and pain.  Medications: NSAIDS, simple nonopioid analgesics like paracetamol (acetaminophen), opioids and adjuvant medications (antidepressants), topicals -simple counter-irritants, , anaesthetic agents such as ketamine, topical tricyclic antidepressants or capsaicin, injectables such as hyaluronic acid and gluco-corticosteroids. 8  Botulinum toxin type B. 9
